Selected article for: "immune response and PubMed search"
Author: Roudbary, Maryam; Kumar, Sunil; Kumar, Awanish; Černáková, Lucia; Nikoomanesh, Fatemeh; Rodrigues, Célia F.
Title: Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
  • Cord-id: bs9rzzde
  • Document date: 2021_9_2
    • ID: bs9rzzde
    Snippet: Patients with severe COVID-19, such as individuals in intensive care units (ICU), are exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal infections are aspergillosis and candidemia. Nonetheless, other fungal species (for instance, Histoplasma spp., Rhizopus spp., Mucor spp., Cryptococcus spp.) have recently been increasingly linked to opportunistic fungal diseases in COVID-19 patients. These fungal co-infections are described with rising incidence, severe ill
    Document: Patients with severe COVID-19, such as individuals in intensive care units (ICU), are exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal infections are aspergillosis and candidemia. Nonetheless, other fungal species (for instance, Histoplasma spp., Rhizopus spp., Mucor spp., Cryptococcus spp.) have recently been increasingly linked to opportunistic fungal diseases in COVID-19 patients. These fungal co-infections are described with rising incidence, severe illness, and death that is associated with host immune response. Awareness of the high risks of the occurrence of fungal co-infections is crucial to downgrade any arrear in diagnosis and treatment to support the prevention of severe illness and death directly related to these infections. This review analyses the fungal infections, treatments, outcome, and immune response, considering the possible role of the microbiome in these patients. The search was performed in Medline (PubMed), using the words “fungal infections COVID-19”, between 2020–2021.

    Search related documents:
    Co phrase search for related documents
    • administration route and logistic regression analysis: 1
    • administration route and lung infection: 1, 2, 3
    • administration route and lung tissue: 1, 2, 3, 4, 5
    • administration route and lupus erythematosus: 1
    • logistic regression analysis and long term impact: 1, 2, 3, 4, 5, 6, 7
    • logistic regression analysis and low threshold: 1
    • logistic regression analysis and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • logistic regression analysis and lung tissue: 1, 2
    • logistic regression analysis and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7
    • logistic regression analysis multivariate and long term impact: 1, 2, 3, 4
    • logistic regression analysis multivariate and lung infection: 1
    • logistic regression analysis multivariate and lung tissue: 1
    • logistic regression analysis multivariate and lupus erythematosus: 1
    • long term impact and low threshold: 1
    • long term impact and lung infection: 1, 2, 3
    • long term impact and lung tissue: 1
    • long term impact and lupus erythematosus: 1
    • lung tissue and lupus erythematosus: 1, 2, 3, 4